3 结果
FIELD OF THE INVENTION
The present invention relates to the optical isomers of a spiroquinuclidine derivative, to pharmaceutical compositions comprising such isomers, to a method for treating diseases of the central nervous system therewith and to a process for preparing said isomers.
BACKGROUND OF
The present invention relates to new imidazolic compounds. The derivatives according to the invention interact selectively with pre and/or post-synaptic alpha-2 type adrenergic receptors (J. Neurochem. 2001, 78, 685-93) on which they behave as partial agonists, antagonists or reverse agonists. As
The present invention relates to new imidazolic compounds. The derivatives according to the invention interact selectively with pre and/or post-synaptic alpha-2 type adrenergic receptors (J. Neurochem. 2001, 78, 685-93) on which they behave as partial agonists, antagonists or reverse agonists. As